Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

24.87 -0.71 (-2.78%)
Streaming Delayed Price Updated: 9:33 AM EDT, May 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 138,532
Open 24.63
Bid (Size) 24.74 (300)
Ask (Size) 25.00 (1,000)
Prev. Close 25.58
Today's Range 24.37 - 24.99
52wk Range 16.24 - 45.30
Shares Outstanding 308,456,852
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Legend Biotech Q1 Earnings Call Highlights ↗
Legend Biotech (NASDAQ:LEGN) reported sharply higher first-quarter 2026 sales for CARVYKTI, its CAR T therapy for multiple myeloma, as management said demand continued to move into earlier lines of... 
Via MarketBeat
Topics Earnings
Legend Biotech (NASDAQ:LEGN) Q1 2026 Revenue Surges on CARVYKTI Growth, but EPS Falls Short ↗
Via Chartmill

Performance

YTD
+15.6%
+15.6%
1 Month
+40.6%
+40.6%
3 Month
+44.7%
+44.7%
6 Month
-21.3%
-21.3%
1 Year
-23.2%
-23.2%

More News

Read More
News headline image
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million? ↗
Via The Motley Fool
Topics Regulatory Compliance
Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q4 2025 Results, Beats on EPS ↗
Via Chartmill
News headline image
Matthews Just Slashed Its Futu Position -- Here’s Why That Matters ↗
Via The Motley Fool
News headline image
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Why Legend Biotech Stock Crushed the Market on Monday ↗
Via The Motley Fool
News headline image
Legend Biotech (LEGN) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Legend Biotech (LEGN) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗
Via The Motley Fool
News headline image
Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗
Via The Motley Fool
News headline image
Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
From Legend Biotech USA Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Legend Biotech Corporation - American Depositary Shares publicly traded?
Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.
What exchange does Legend Biotech Corporation - American Depositary Shares trade on?
Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?
The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market
What is the current price of Legend Biotech Corporation - American Depositary Shares?
The current price of Legend Biotech Corporation - American Depositary Shares is 24.87
When was Legend Biotech Corporation - American Depositary Shares last traded?
The last trade of Legend Biotech Corporation - American Depositary Shares was at 05/12/26 09:33 AM ET
What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?
The market capitalization of Legend Biotech Corporation - American Depositary Shares is 7.67B
How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?
Legend Biotech Corporation - American Depositary Shares has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.